Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004945350 | SCV005462473 | uncertain significance | Hereditary cancer-predisposing syndrome | 2024-11-15 | criteria provided, single submitter | clinical testing | The p.R153P variant (also known as c.458G>C), located in coding exon 3 of the NTHL1 gene, results from a G to C substitution at nucleotide position 458. The arginine at codon 153 is replaced by proline, an amino acid with dissimilar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. |